Bruce Quinn, M.D., Ph.D., is an independent professional collaborating with Faegre Drinker Consulting on Medicare policy, the impact of health reform on innovation and the crafting of successful business strategies within the U.S. health care reimbursement system. He has worked successfully with large and small companies in overcoming hurdles to commercialization through negotiation, understanding insightful ways to use the existing system to advantage and the mechanisms of policy change.
Dr. Quinn has traveled nationwide to speak on health reform issues and written peer-reviewed policy articles on advanced diagnostics and a series of white papers on the 2012-14 coding reform process for genomic tests. Previously, he served as the regional Medicare medical director for the California Part B program, where he had authority for final coverage decisions on approximately 15 percent of the U.S. Medicare program. Earlier, Dr. Quinn was a physician executive in the health and life sciences division of Accenture, working with the pharma, biotech and genomics industries.
Debra R. Lappin
Principal - Science & Regulatory Policy - Faegre Drinker Consulting